GlobalRPh Renal Dosing Masterv6.6
Source review / handoff

Levofloxacin

One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.

Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.

Share or print this source review

1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.

Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.

Clinical context remains essential

Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.

Historical indication, duration and organism material is retained. This import does not establish that these are preferred current treatment choices.

Check source scope before reading a dose

UCSF - levofloxacin

Product / population
Adult systemic levofloxacin; treatment regimens. Heme/BMT prophylaxis is a separate source regimen.
Renal method
CrCl in mL/min where specified; no equation inferred.
Source revision
Revision date not stated in the reviewed page.
Retrieved
2026-09-05
Local review status
Locally included source-specific summary. Regimen differences are not automatically resolved.

Documented differences and cautions on this drug

All record notes are retained here, including notes about sources not selected in this review.

Select the usual regimen before the renal row

The 750, 500 and 250 mg renal paths differ. The 250 mg row has a specific uncomplicated-UTI exception and lacks dialysis adjustment information.

What to reconcile: Retain indication, usual dose, loading dose and maintenance interval together.

Source-specific interpretation; independent clinician adjudication pending.

Open this note and its source references
Professional

UCSF - levofloxacin

Open original reference

UCSF Infectious Diseases Management Program · Adult systemic levofloxacin; treatment regimens. Heme/BMT prophylaxis is a separate source regimen.

Renal method: CrCl in mL/min where specified; no equation inferred.
Source date: Revision date not stated in the reviewed page.
Retrieved: 2026-09-05

Locally included source-specific summary. Regimen differences are not automatically resolved.

Dosing / renal protocol and limits

Limits that apply to these rows

Exactly 50 is unassigned in this source. Separate oral doses from multivalent cations by at least 2 hours.

UTI treatment - IV/oral
CrCl, mL/minSource-specific dose / instruction
>50500 mg every 24 hours
20-49500 mg once, then 250 mg every 24 hours
<20500 mg once, then 250 mg every 48 hours
Other infections - IV/oral
CrCl, mL/minSource-specific dose / instruction
>50750 mg every 24 hours
20-49750 mg every 48 hours
<20750 mg once, then 500 mg every 48 hours
Dialysis guidance - separate source-specific schedules
Levofloxacin dialysis
Dialysis setting / indicationSource-specific schedule
IHD standard500 mg once, then 250 mg every 48 hours
IHD pneumonia/Gram-negative bacteremia/Pseudomonas750 mg once, then 500 mg every 48 hours
CVVHD standard750 mg once, then 250 mg every 24 hours
CVVHD pneumonia/bacteremia/Pseudomonas750 mg once, then 500 mg IV every 24 hours
Read the retained text before reformatting

For CrCl >50 / 20-49 / <20 mL/min, UTI treatment uses 500 mg IV/orally daily / 500 mg once then 250 mg daily / 500 mg once then 250 mg every 48 hours. Other infections use 750 mg daily / 750 mg every 48 hours / 750 mg once then 500 mg every 48 hours.

IHD standard: 500 mg once then 250 mg every 48 hours. IHD pneumonia, Gram-negative bacteremia or Pseudomonas: 750 mg once then 500 mg every 48 hours.

CVVHD standard: 750 mg once then 250 mg daily; pneumonia/bacteremia/Pseudomonas: 750 mg once then 500 mg IV daily. Oral doses require separation from multivalent cations by at least 2 hours.

The exact CrCl 50 boundary is not allocated by the displayed >50 / 20-49 columns.

RDM30-015-levofloxacin-1 · Source locator: UCSF - levofloxacin; renal/dosing sections and stated qualifiers

Source identity and provenance
Source
https://idmp.ucsf.edu/content/levofloxacin
Retrieved
2026-09-05
Renal-function method
CrCl in mL/min where specified; no equation inferred.
Source date/version
Revision date not stated in the reviewed page.
Hash meaning
Locally authored summary text; not original SPL, HTML or PDF bytes
Local summary SHA-256
3e51fc2d5816170a3bb4627678ac65c54c96024947dcc4e3d092090f7a749da5

Document the clinical decision separately

This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.

GlobalRPh v6.6 | RDM66-DIRECT-PHP-20260911 | Local library date 2026-09-11. Selected-card identity does not imply clinical verification.

Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=levofloxacin&s1=RDM30-015-levofloxacin&h1=6748148cb53d8e11d610864959271beddaae6803c22b19a6e796db379b302504